Supplementary Figures
Supplementary Figure S1 . Biphasic killing curves of P. aeruginosa PAO1, PDO300, E. coli K12, and E. coli ATCC53505 cells collected from exponential and stationary phase cultures. P. aeruginosa PAO1 cells collected from exponential (a) and stationary (b) phase cultures were treated with 200 µg/mL ciprofloxacin (Cip). P. aeruginosa PDO300 cells collected from exponential (c) and stationary (d) phase cultures were treated with 200 µg/mL ciprofloxacin (Cip). E. coli K12 cells collected from exponential (e) and stationary (f) phase cultures were treated with 100 µg/mL ampicillin (Amp). E. coli ATCC 53505 cells collected from exponential phase cultures (g) were treated with 20 µg/mL ofloxacin (Ofl). The samples were tested in triplicate (n=3). Error bars represent SD. Supplementary Table S1 . MIC of ciprofloxacin, tobramycin, tetracycline, and gentamicin for strains P. aeruginosa PAO1, P. aeruginosa PDO300, and E. coli K12.
Supplementary Tables

Bacterial strain
Antibiotic MIC Ciprofloxacin Tobramycin Tetracycline Gentamicin P. aeruginosa PAO1 3.2 µg/mL 0.8 µg/mL 12.8 µg/mL 6.4 µg/mL P. aeruginosa PDO300 6.4 µg/mL 3.2 µg/mL 25.6 µg/mL 6.4 µg/mL E. coli K12 0.4 µg/mL 0.4 µg/mL 0.8 µg/mL 3.2 µg/mL 
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